Stephens Investment Management Group LLC Has $10.57 Million Position in Henry Schein, Inc. $HSIC

Key Points

• Stephens Investment Management Group LLC reduced its stake in Henry Schein, Inc. by 15.3%, owning approximately $10.57 million worth of shares after selling 26,174 shares in the second quarter.
• Henry Schein's stock currently has a market cap of $7.70 billion and is trading down 1.1%, with a recent 52-week low of $60.56 and a high of $82.49.
• Analysts have mixed ratings for Henry Schein, with reports showing price target adjustments, including a cut from $80.00 to $76.00 by JPMorgan Chase & Co., while the average price target stands at $76.67.

Stephens Investment Management Group LLC reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 15.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 144,750 shares of the company's stock after selling 26,174 shares during the period. Stephens Investment Management Group LLC owned about 0.12% of Henry Schein worth $10,574,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of HSIC. Vanguard Personalized Indexing Management LLC lifted its position in shares of Henry Schein by 3.5% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company's stock valued at $341,000 after buying an additional 157 shares during the last quarter. Equitable Trust Co. lifted its position in shares of Henry Schein by 3.1% in the second quarter. Equitable Trust Co. now owns 5,317 shares of the company's stock valued at $388,000 after buying an additional 158 shares during the last quarter. TD Asset Management Inc lifted its position in shares of Henry Schein by 0.8% in the second quarter. TD Asset Management Inc now owns 22,016 shares of the company's stock valued at $1,608,000 after buying an additional 164 shares during the last quarter. Radnor Capital Management LLC lifted its position in shares of Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company's stock valued at $834,000 after buying an additional 180 shares during the last quarter. Finally, V Square Quantitative Management LLC lifted its position in shares of Henry Schein by 6.3% in the second quarter. V Square Quantitative Management LLC now owns 3,377 shares of the company's stock valued at $247,000 after buying an additional 200 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Down 1.1%

Shares of HSIC opened at $63.51 on Thursday. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The business's fifty day moving average is $66.90 and its 200-day moving average is $68.53. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm has a market cap of $7.70 billion, a price-to-earnings ratio of 20.49, a PEG ratio of 2.12 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the business posted $1.23 EPS. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. UBS Group dropped their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Leerink Partners set a $75.00 price target on Henry Schein in a report on Monday, July 14th. Barrington Research reissued an "outperform" rating and set a $78.00 price target on shares of Henry Schein in a report on Wednesday. Finally, JPMorgan Chase & Co. dropped their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Five equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.